Skip to main content

Kappa Therapeutics

Seattle, Washington·EIN 46-0688971·NTEE H03 · Medical Research·501(c)(3)·Filing year 2024
Total revenue
$16k
Total assets
$34k
Total expenses
$848
Reported officers
1

How Kappa Therapeutics’s pay compares

Its latest Form 990 lists no roles we can compare, so there is no comparison for it yet.

Chief Executive Officer pay at Medical Research organizations of similar size in the West

25th
$11k
Median
$22k
75th
$50k

From the Form 990 filings of 16 Medical Research organizations of similar size in the West.

See Chief Executive Officer pay in full

Reported officers (all unpaid)

No paid executives reported in 2024. Kappa Therapeutics reported 1 unpaid officer or board member on its 990-EZ.

Secretary/treasurer

Revenue and expenses over time

Kappa Therapeutics reported revenue and expenses across 3 filing years.

RevenueExpenses
$2
$5k
2022
$9k
$32k
2023
$16k
$848
2024
Total revenue and total expenses from IRS Form 990 filings.

What the Chief Executive Officer earns at organizations like this one

Kappa Therapeutics reported no executive compensation in its latest filing. For context, the Chief Executive Officer at Medical Research organizations of similar size in the West earns a median of $22,000.

25th percentile
$11k
Median
$22,000
75th percentile
$50k
90th percentile
$199k

These are pay figures for organizations like this one, not this organization's reported pay. Based on 16 organizations. There were too few similar organizations to compare with, so this group goes beyond Washington.

See full Medical Research compensation data →

Common questions about Kappa Therapeutics

What are Kappa Therapeutics's revenue and expenses?

In 2024, Kappa Therapeutics reported $16k in total revenue and $848 in total expenses on its IRS Form 990.